| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/2007 | EP1742062A2 Protein arrays for allelic variants and uses thereof |
| 01/10/2007 | EP1742059A1 Use of PTA peptides for stratification of individuals having cancer |
| 01/10/2007 | EP1742058A2 Substrate for analyte determination and methods for manufacturing such substrates |
| 01/10/2007 | EP1741793A1 Method of hybridization |
| 01/10/2007 | EP1741792A1 Novel ligand of g-protein-conjugated receptor protein and use thereof |
| 01/10/2007 | EP1741789A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 01/10/2007 | EP1741788A1 Transgenic plant with tissue-selectively reduced cytokinin receptor activity |
| 01/10/2007 | EP1741787A1 DNA joining method |
| 01/10/2007 | EP1741786A1 Method of separating precusror cells of liver cells, endothelial cells or hematopoietic cells from cell mass |
| 01/10/2007 | EP1741785A1 Porcine circoviruses, nucleic acids, polypeptides and vaccines |
| 01/10/2007 | EP1741784A1 85kDa neisserial antigen |
| 01/10/2007 | EP1741783A1 Human antiamyloid beta peptide antibody and antibody fragment thereof |
| 01/10/2007 | EP1741782A2 Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
| 01/10/2007 | EP1741781A2 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA) |
| 01/10/2007 | EP1741780A2 High affinity oligonucleotide ligands to growth factors |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741778A1 Procedure for the treatment of small volumes with electric current |
| 01/10/2007 | EP1741777A1 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741721A1 Method for production of a compound in a eukaryotic cell |
| 01/10/2007 | EP1741720A1 Modified DNA molecule, recombinant containing the same, and uses thereof |
| 01/10/2007 | EP1741718A2 Expression of lipoproteins |
| 01/10/2007 | EP1741670A1 Device incorporating a field of dots used in biotechnology applications |
| 01/10/2007 | EP1741449A1 Preventive and/or remedy for cancer |
| 01/10/2007 | EP1740725A2 Biological bar code |
| 01/10/2007 | EP1740722A1 Method and assembly for dna isolation with dry reagents |
| 01/10/2007 | EP1740721A1 Pcr process and arrangement for dna amplification using dry reagents |
| 01/10/2007 | EP1740713A2 Synthetic genes |
| 01/10/2007 | EP1740705A2 Methods and materials for improving plant drought tolerance |
| 01/10/2007 | EP1740704A2 Systemic gene silencing in plants |
| 01/10/2007 | EP1740703A1 Multiple heat shock elements |
| 01/10/2007 | EP1740702A2 Canine ghrh gene, polypeptides and methods of use |
| 01/10/2007 | EP1740701A1 Osteogenic growth peptide fusion proteins |
| 01/10/2007 | EP1740700A1 Exo-endo cellulase fusion protein |
| 01/10/2007 | EP1740699A1 Connexin 40 tissue specific gene mutations |
| 01/10/2007 | EP1740611A2 Ion channel |
| 01/10/2007 | EP1740607A2 Methods for modifying plant characteristics |
| 01/10/2007 | EP1740606A2 Cytokinin oxidase sequences and methods of use |
| 01/10/2007 | EP1740603A2 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 01/10/2007 | EP1740602A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 01/10/2007 | EP1740600A1 Intracellular delivery of osteoinductive proteins and peptides |
| 01/10/2007 | EP1740219A2 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 01/10/2007 | EP1740218A1 Materials for treating vascular leakage in the eye |
| 01/10/2007 | EP1740210A2 Irta-5 antibodies and their uses |
| 01/10/2007 | EP1740208A2 Monoclonal antibodies specific for human ox40l (cd134l) |
| 01/10/2007 | EP1740107A1 Electromagnetic treatment apparatus and method |
| 01/10/2007 | EP1740039A2 Novel herbicide resistance genes |
| 01/10/2007 | EP1578969A4 A method for optimising gene expression using synonymous codon optimisation |
| 01/10/2007 | EP1513876B1 Human 5-ht7 receptor promoter sequence |
| 01/10/2007 | EP1485129B1 Nanostructures containing pilin protein |
| 01/10/2007 | EP1476575A4 Detection of single nucleotide polymorphisms using planar waveguides |
| 01/10/2007 | EP1466979B1 Fungus-origin lysyl oxidases |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1412509B1 Rna amplification system using plant components in animal cells |
| 01/10/2007 | EP1339745B1 Immunotherapeutic methods and molecules |
| 01/10/2007 | EP1337846B1 Arrangement for the production testing and archiving of chemical or biological arrays bonded to a solid phase |
| 01/10/2007 | EP1301534B1 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 01/10/2007 | EP1232180B1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 01/10/2007 | EP1228233B1 Methods and compositions comprising renilla gfp |
| 01/10/2007 | EP1129213B1 Bacillus strain and assay methods |
| 01/10/2007 | EP1113777B1 Novel hepatitis c virus peptides and uses thereof |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | EP1017723B1 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 01/10/2007 | EP1015613B1 Control pod dehiscence or shatter |
| 01/10/2007 | EP0949331B1 Established microglia |
| 01/10/2007 | EP0934423B1 Aav-dna helper virus sequences |
| 01/10/2007 | EP0918796B1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 01/10/2007 | EP0914440B1 Nucleic acid vaccination for parvoviral infections |
| 01/10/2007 | EP0911393B1 Peptide having cortistatin or somatostatin activity, process for the production of the same, and use of the same |
| 01/10/2007 | EP0873422B1 Method for generating multiple double stranded nucleic acids |
| 01/10/2007 | EP0868527B1 Process for the microbial production of amino acids by boosted activity of export carriers |
| 01/10/2007 | EP0851940B1 Methods of using nucleotide integrase for cleaving dna and attaching nucleic acids |
| 01/10/2007 | EP0812357B1 A method for making heteromultimeric polypeptides |
| 01/10/2007 | EP0782580B1 Parallel selex |
| 01/10/2007 | EP0733112B1 Cytochrome p-450 monooxygenases |
| 01/10/2007 | CN1894581A Method for assaying protein-protein interaction |
| 01/10/2007 | CN1894424A Thiamin production by fermentation |
| 01/10/2007 | CN1894416A Methods for the preparation of a fine chemical by fermentation |
| 01/10/2007 | CN1894415A Methods for the preparation of a fine chemical by fermentation |
| 01/10/2007 | CN1894413A Activation of tumor reactive lynphatic cell of identifying CD3 or 4-1BB antibody or gene mediation |
| 01/10/2007 | CN1894412A P EF-TU expression units |
| 01/10/2007 | CN1894411A PSOD expression units |
| 01/10/2007 | CN1894410A DNA-sequence and recombinant production of group 4 major allergens from cereals |
| 01/10/2007 | CN1894409A Human LXR alpha variants |
| 01/10/2007 | CN1894408A Metabolic protein for weed-control agent, its gene, and its use |
| 01/10/2007 | CN1894407A Nucleic acids specifically binding bioactive ghrelin |
| 01/10/2007 | CN1894406A Antibody composition-producing cell |
| 01/10/2007 | CN1894405A Arachidonic acid-containing plant and utilization of the same |
| 01/10/2007 | CN1894404A Promoter in the presence of organic acid and utilization thereof |
| 01/10/2007 | CN1894403A Recombined small-mouse leukovirus reverse transcriptase and coding gene and expression method |
| 01/10/2007 | CN1894402A FLP-mediated recombination |
| 01/10/2007 | CN1894398A Modification of protein glycosylation in methylotrophic yeast |
| 01/10/2007 | CN1894280A Glycosylation-deficient hepatocyte growth factor |
| 01/10/2007 | CN1894278A Akt activity specifically inhibiting polypeptide |
| 01/10/2007 | CN1894276A HCV NS3-NS4A protease resistance mutants |
| 01/10/2007 | CN1894275A Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 01/10/2007 | CN1894272A 蛋白质表达 Protein expression |
| 01/10/2007 | CN1893981A Methods and compositions for treatment of interferon-resistant tumors |
| 01/10/2007 | CN1893975A Medicament comprising inhibitors of long pentraxin ptx3 |